WHAT IS MOUNJARO?

Mounjaro is a once-weekly injectable medication developed by Eli Lilly for the treatment of type 2 diabetes. Its active ingredient, tirzepatide, is the first in a new class of medications that targets two gut hormones — GLP-1 and GIP — to improve blood click here sugar levels and support weight reduction.SEO Keywords:What is Mounjaro?Tirzepatid

copyright is administered via a pre-filled pen once a week. The typical starting dose is 0.25 mg, gradually increasing to 1 mg click here or 2 mg depending on the patient's response.Tips for Best Use:Inject on the same day each weekUse in combination with diet and exerciseFollow up regularly with your healthcare provider